Depression and Anxiety Trial, Recruiting (NCT05379673)

Depression and Anxiety Trial, Recruiting NCT05379673 Sponsor: Stanford University Condition: Depression and Anxiety

Printed from Voxsanity (voxsanity.com.au) — NCT05379673 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Depression And Anxiety

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People classified as having a low to moderate health risk for surgery (a rating given by an anaesthetist before an operation, known as ASA status I, II, or III)
People with a body mass index (a measure of body weight relative to height) below 40
People who are scheduled to have a robot-assisted keyhole surgery to remove a kidney or the prostate gland

Who may not be able to join:

People who have been diagnosed with chronic obstructive pulmonary disorder (a long-term lung condition), severe neurological (brain or nerve), heart or lung, psychiatric (mental health), or untreated thyroid conditions
People who have ongoing long-term pain that is currently being managed with opioid pain medications (such as morphine or similar strong painkillers)
People whose blood count (a measure of red blood cells) falls below a certain level at the end of surgery, or who experience significant blood loss during surgery that requires a blood transfusion

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Anthony Doufas, MD, PhD, Professor, Department of Anesthesiology, Stanford University Medical School

Phone: 650-498-7699

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05379673

Sponsor: Stanford University

Phase: Not Applicable

Status: Recruiting

Condition: Depression and Anxiety

Trial contact: 650-498-7699

More information: https://clinicaltrials.gov/study/NCT05379673

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People classified as having a low to moderate health risk for surgery (a rating given by an anaesthetist before an operation, known as ASA status I, II, or III)
People with a body mass index (a measure of body weight relative to height) below 40
People who are scheduled to have a robot-assisted keyhole surgery to remove a kidney or the prostate gland

Who may not be able to join:

People who have been diagnosed with chronic obstructive pulmonary disorder (a long-term lung condition), severe neurological (brain or nerve), heart or lung, psychiatric (mental health), or untreated thyroid conditions
People who have ongoing long-term pain that is currently being managed with opioid pain medications (such as morphine or similar strong painkillers)
People whose blood count (a measure of red blood cells) falls below a certain level at the end of surgery, or who experience significant blood loss during surgery that requires a blood transfusion

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Stanford University

Registry

ClinicalTrials.gov

Start date

4 October 2022

Est. completion

1 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Transcutaneous partial pressure of carbon dioxide (TcPCO2)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov